EUVIMEDOpdag EUVIMED
Open access · CC BY-NC 4.0

Low 25 (OH) vitamin D levels are associated with increased prevalence of nonalcoholic fatty liver disease and significant liver fibrosis

Stefano Ciardullo iD, Emanuele Muraca, Rosa Cannistraci, Silvia Perra, Guido Lattuada, Gianluca Perseghin iD

Diabetes/Metabolism Research and Reviews · 2023-07 · 39 (5)

DOI: 10.1002/dmrr.3628 ↗

At a glance

Journal article in Diabetes/Metabolism Research and Reviews, published online on 2023-03-09. Written by Stefano Ciardullo and 5 co-authors. Institution: Department of Medicine and Rehabilitation, Policlinico di Monza, Monza, Italy. Major MEDLINE topics: Non-alcoholic Fatty Liver Disease. Cited 32 times so far (Crossref); 50 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Aims

Evidence on the role of 25‐Hydroxyvitamin D (25(OH)D) in the occurrence and progression of nonalcoholic fatty liver disease (NAFLD) is conflicting and population‐based data are scarce. Here, we assess the association between 25(OH)D levels, NAFLD and liver fibrosis in the general population. Materials and Methods This is an analysis of data from the 2017–2018 cycle of the National Health and Nutrition Examination Survey. We included adult participants with available data on vibration‐controlled transient elastography (VCTE) and without viral hepatitis and significant alcohol consumption. Steatosis and fibrosis were diagnosed by the median values of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM), respectively. 25(OH)D was measured by high performance liquid chromatography‐tandem mass spectrometry.

Results

A total of 3970 participants (1928 men and 2042 women) were included in the study. The prevalence of NAFLD (CAP ≥ 274 dB/m) and significant liver fibrosis (LSM ≥ 8 kPa) were 41.7% (95% CI 39.4–44.0) and 8.4% (95% CI 7.0–9.9), respectively, while 21.1% (95% CI 17.3–25.4) of participants had low 25(OH)D levels (

Subjects

MeSH terms (MEDLINE)

Non-alcoholic Fatty Liver DiseaseAdultMaleHumansFemalePrevalenceNutrition SurveysLiver CirrhosisVitamin DLiver

Author keywords

NAFLDcholecalciferolergocalciferolfibroscanfibrosisvitamin D

Substances

Vitamin D

Authors and institutions

  • Department of Medicine and Rehabilitation, Policlinico di Monza, Monza, Italy.
  • Department of Medicine and Surgery, Università degli Studi di Milano Bicocca, Monza, Italy.

ORCID profiles: Stefano Ciardullo, Gianluca Perseghin

Cite

APA

Ciardullo, S., Muraca, E., Cannistraci, R., Perra, S., Lattuada, G., & Perseghin, G. (2023). Low 25 (OH) vitamin D levels are associated with increased prevalence of nonalcoholic fatty liver disease and significant liver fibrosis. Diabetes/Metabolism Research and Reviews, 39(5). https://doi.org/10.1002/dmrr.3628

Vancouver

Ciardullo S, Muraca E, Cannistraci R, Perra S, Lattuada G, Perseghin G. Low 25 (OH) vitamin D levels are associated with increased prevalence of nonalcoholic fatty liver disease and significant liver fibrosis. Diabetes/Metabolism Research and Reviews. 2023;39(5). doi:10.1002/dmrr.3628

BibTeX
@article{Ciardullo2023,
  author = {Ciardullo, Stefano and Muraca, Emanuele and Cannistraci, Rosa and Perra, Silvia and Lattuada, Guido and Perseghin, Gianluca},
  title = {Low 25 (OH) vitamin D levels are associated with increased prevalence of nonalcoholic fatty liver disease and significant liver fibrosis},
  journal = {Diabetes/Metabolism Research and Reviews},
  year = {2023},
  volume = {39},
  number = {5},
  doi = {10.1002/dmrr.3628}
}
Start for free →